The effect of cream and ointment bases on the steady state penetration of permeants through intact skin: The reciprocal of the onset time of a pharmacodynamic effect as parameter of response

International Journal of Cosmetic Science

Volumn 22, Issue 2, 2000, Pages 133-145

  Leopold, C S ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Penetration enhancement; Pharmacodynamic response; Relative bioavailability; Vehicle effects; Zero order kinetics

Indexed keywords

COSMETIC; DRUG VEHICLE; OINTMENT BASE;

ARTICLE; BIOAVAILABILITY; DIFFUSION COEFFICIENT; HUMAN; KINETICS; SKIN CARE; SKIN PENETRATION; SOLUBILITY; STRATUM CORNEUM; TIME;

EID: 0034089194     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1467-2494.2000.00013.x     Document Type: Article

References (17)

1. 1. Lippold, B.C. and Teubner, A. Einfluß verschiedener Salbengrundlagen auf die Wirkung von Nicotinsäurebenzylester in Lösungssalben. Pharm. Ind. 43, 1123-1133, (1981).
2. 2. Lippold, B.C. and Schneemann, H. The influence of vehicle on the local bioavailability of betamethason-17-benzoate from solution-and suspension-type ointments. Int. J. Pharm. 22, 31-43, (1984).
3. 3. Lippold, B.C. and Reimann, H. Wirkungsbeeinflussung bei Lösungssalben durch Vehikel am Beispiel von Methylnicotinat, Teil H. Beziehung zwischen relativer thermodynamischer Aktivität und Bioverfügbarkeit: Penetrationsbeschleunigung und Entleerungseffekt. Acta Pharm. Technol. 35, 136-142, (1989).
4. 4. Lippold, B.C. and Hackemüller, D. The influence of skin moisturizers on drug penetration in vivo. Int. J. Pharm. 61, 205-211, (1990).
5. 5. Bach, M. and Lippold, B.C. Influence of penetration enhancers on the blanching intensity of betamethasone 17-benzoate. Int. J. Pharm. 168, 97-108, (1998).
6. 6. Beastall, J, Guy, R.H, Hadgraft, J. and Wilding, I. The influence of urea on percutaneous absorption. Pharm. Res. 5, 294-297, (1986).
7. 7. Boonsaner, P, Hadgraft, J. and Pugh, W.J. Mechanism of action of oleic acid and propylene glycol as skin penetration enhancers. Proc. Int. Symp Controlled Release Bioact. Mater. 22, 650-651, (1995).
8. 8. Stoughton, R.B. Bioassay methods for measuring percutaneous absorption. In: Advances in Biology of Skin (W. Montagna, E. J. van Scott and R. B. Stoughton, eds), pp. 542-573. Appleton, New York, (1969).
9. 9. Barry, B.W. and Woodford, R. Activity and bioavailability of topical steroids. In vivo/in vitro correlations for the vasoconstrictor assay. J. Clin. Pharm. 3, 43-65, (1978).
10. 10. Leopold, C.S. and Maibach, H.I. Percutaneous penetration of local anesthetic bases: Pharmacodynamic measurements. J. Invest. Dermatol, 113, 304-307 (1999).
11. 11. Leopold, C.S. How accurate is the determination of the relative bioavailability of transdermal drug formulations from pharmacodynamic response data? Pharm. Acta Helv. 73, 63-67, (1998).
12. 12. Crank, J. Mathematics of Diffusion. Oxford University Press, London, (1956).
13. 13. Leopold, C.S. Quantification of depletion in solution-type topical preparations in vivo. J. Cosmet. Sci. 49, 165-174, (1998).
14. 14. Leopold, C.S. and Lippold, B.C. Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo. J. Pharm. Sci. 84, 195-198, (1995).
15. 15. Lippold, B.C. and Reimann, H. Wirkungsbeeinflussung bei Lösungssalben durch Vehikel am Beispiel von Methylnicotinat, Teil I. Relative thermodynamische Aktivität des Arzneistoffes in verschiedenen Vehikeln und Freisetzungsverhalten. Acta Pharm. Technol. 35, 128-135, (1989).
16. 16. Albery, W.J. and Hadgraft, J. Percutaneous absorption: theoretical description. J. Pharm. Pharmacol. 31, 129-139, (1979).
17. 17. Albery, J. and Hadgraft, J. Percutaneous absorption: in vivo experiments. J. Pharm. Pharmacol. 31, 140-147, (1979).